CIK 0001447028
- Non-accelerated filer
- Smaller reporting company
Arbutus Biopharma Corp
Sign in to watch- Ticker
- ABUS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- Operating
- EIN
- 980597776
- Phone
- +1 604-419-3200
- Business address
- 701 VETERANS CIRCLE, WARMINSTER, PA, 18974
- Former names
- TEKMIRA PHARMACEUTICALS CORP, TEKMIRA PHARMACEUTICALS Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-01 | Collier William H. President and CEO | Grant or award | +216,500 | 216,500 | ||
| 2023-02-01 | Collier William H. President and CEO | Grant or award · Stock Option (Right to Buy) | +866,000 | 866,000 | ||
| 2022-01-20 | Collier William H. President and CEO | Grant or award · Stock Option (Right to Buy) | +787,550 | $2.81 | $2.2M | 787,550 |
| 2021-02-13 | Collier William H. President and CEO | Grant or award · Stock Options | +675,000 | 675,000 | ||
| 2020-09-23 | Collier William H. President and CEO | Grant or award · Stock Options | +70,000 | 70,000 | ||
| 2020-05-28 | Collier William H. President and CEO | Grant or award · Stock Options | +262,313 | 262,313 | ||
| 2020-02-17 | Collier William H. President and CEO | Grant or award · Stock Options | +367,087 | 367,087 | ||
| 2019-06-24 | Collier William H. President and CEO | Grant or award · Employee Stock Option (Right to Buy) | +1,112,000 | 1,112,000 |
Page 1 of 1 · 8 trades